Latest 10-K annual reports

Vaxart, Inc. filed an amendment to its 2025 Annual Report to provide required Part III disclosures regarding directors, executive compensation, and corporate governance.

Dawson Geophysical Company filed an amendment to its 2025 Annual Report to provide required disclosures regarding directors, executive compensation, and corporate governance.

Cannae Holdings files an amendment to its 2025 Annual Report to update governance, executive compensation, and director disclosures.

Grid Dynamics Holdings, Inc. filed an amendment to its 2025 Annual Report to include proxy statement disclosures and updated Sarbanes-Oxley certifications.

Traws Pharma, Inc. filed an amendment to its 2025 Annual Report to provide required Part III corporate governance and executive compensation disclosures.

KalVista Pharmaceuticals files an amendment to its transition report to include required governance and compensation disclosures ahead of its pending merger.

Whitestone REIT filed an amendment to its 2025 Annual Report to include proxy information and updated certifications following a deferred annual meeting.

LivePerson files an amendment to its 2025 Annual Report on Form 10-K to include required Part III disclosures regarding executive compensation and corporate governance.

CERo Therapeutics Holdings, Inc. filed an amendment to its 2025 Annual Report to provide required Part III disclosures regarding directors, executive compensation, and governance.

Splash Beverage Group files an amendment to its 2025 Annual Report to include required Part III disclosures regarding governance and executive compensation.

Genco Shipping & Trading Limited filed an amendment to its 2025 Annual Report to provide required Part III disclosures regarding executive compensation and corporate governance.

Catalyst Pharmaceuticals, Inc. filed an amendment to its 2025 Annual Report to include required governance and executive compensation disclosures.

Edible Garden AG Incorporated filed an amendment to its 2025 Annual Report to include required governance and compensation disclosures.

CNS Pharmaceuticals, Inc. filed an amendment to its 2025 Annual Report to provide required disclosures regarding directors, executive compensation, and corporate governance.

TuHURA Biosciences files an amendment to its 2025 Annual Report to include missing proxy information and correct management discussion disclosures.

Interpace Biosciences filed an amendment to its 2025 Annual Report to include required proxy statement disclosures.

LENSAR, Inc. filed an amendment to its 2025 Annual Report to provide required disclosures regarding directors, executive compensation, and corporate governance.

Greenlane Holdings amends its 2025 Annual Report to provide updated governance, executive compensation, and digital asset strategy disclosures.

Synlogic, Inc. filed an amendment to its 2025 Annual Report to provide previously omitted disclosures regarding corporate governance, executive compensation, and related party transactions.

RE/MAX Holdings, Inc. filed an amendment to its 2025 Annual Report to include required Part III proxy information and updated executive certifications.

RingCentral, Inc. filed an amendment to its 2025 Annual Report to include required Part III disclosures regarding directors, executive compensation, and corporate governance.

International Money Express, Inc. filed an amendment to its 2025 Annual Report to provide required proxy statement disclosures.

Navitas Semiconductor Corporation filed an amendment to its 2025 Annual Report to provide required disclosures regarding executive compensation, corporate governance, and director information.

Achieve Life Sciences amends its 2025 Annual Report to include updated corporate governance, executive compensation, and director information.

Ready Capital Corporation filed an amendment to its 2025 Annual Report to provide required disclosures regarding directors, executive compensation, and corporate governance.

ASP Isotopes Inc. filed an amendment to its 2025 Annual Report to provide required disclosures regarding executive compensation, corporate governance, and director information.

MicroVision, Inc. filed an amendment to its 2025 Annual Report to provide required Part III disclosures regarding executive compensation and corporate governance.

OneMedNet Corporation filed an amendment to its 2025 Annual Report to include required Part III disclosures regarding governance and executive compensation.

Safe Pro Group Inc. filed an amendment to its 2025 Annual Report to provide required disclosures regarding directors, executive compensation, and corporate governance.

Wave Life Sciences Ltd. filed an amendment to its 2025 Annual Report to include required Part III disclosures and updated certifications.